These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 4057574

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Chemotherapy of urologic malignancies.
    Scher HI, Sternberg CN.
    Semin Urol; 1985 Nov; 3(4):239-80. PubMed ID: 3916569
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [The combined treatment of patients with locally disseminated prostatic cancer].
    Matveev BP, Iiazaliev KT.
    Urol Nefrol (Mosk); 1993 Nov; (4):21-5. PubMed ID: 8310560
    [Abstract] [Full Text] [Related]

  • 25. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
    Pansadoro V, Emiliozzi P.
    Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Intra-arterial infusion of antineoplastic agents in the treatment of urogenital cancer].
    Uyam T, Moriwaki S.
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):415-20. PubMed ID: 7184407
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The systemic therapy of urologic cancer.
    Marsh JC.
    Conn Med; 1980 Apr; 44(4):217-24. PubMed ID: 7371401
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Genitourinary cancer.
    Ozols RF, Yagoda A.
    Cancer Chemother Biol Response Modif; 1990 Apr; 11():602-29. PubMed ID: 2171615
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Organ preservation in the management of bladder and prostate cancer.
    Vitale V.
    Rays; 1997 Apr; 22(3):406-9. PubMed ID: 9446944
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Urogenital cancer].
    Koiso K, Rinsho K, Nemoto R, Ishikawa H, Ohtani M, Uchida K, Noguchi R.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):971-7. PubMed ID: 2658819
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Treatment options in androgen-independent prostate cancer.
    Lara PN, Meyers FJ.
    Cancer Invest; 1999 Apr; 17(2):137-44. PubMed ID: 10071598
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.